Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Max Gelman - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Senior Editor, Endpoints News

Max Gelman

Verified

Senior Editor, Endpoints News

New York

Beats

Primary beats

United StatesHealthEnvironmentMetro New York

Secondary beats

HousingInnovation In BusinessEthicsReal EconomyHumorFaithPublic Health InitiativesNet-ZeroInvestigative FeaturesGeneral NewsDoctorsHealthcare SystemsEnvironmental Issues

Biography

Final Covers

Doesn’t Cover

Not a fan of the blanket embargo.

Journalist Type

Editor

Seniority Positions

Senior

Industries

Online Media

Medium Formats

-

Content

Total articles 1896

  • Available on paid plans

    Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

    By Max Gelman Verified

    Apr. 17, 2025

  • Available on paid plans

    Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

    By Max Gelman Verified

    Apr. 17, 2025

  • Available on paid plans

    Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

    By Max Gelman Verified

    Apr. 17, 2025

As seen in

Invesbrain,Daily Northwestern,Endpoints News,Mlb,New York Daily News,St. Louis Post-Dispatch,The Post Game

Company Info

Endpoints News

Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.

Lawrence, Kansas, United States

+1 785-813-1733

Founded: 2014



Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved